Browse the full record of transactions filed by 김남주, Directeur. Insider active across 2 companies, notably 카나프테라퓨틱스. In total, 17,943 filings have been recorded. Activity tracked since 4 March 2026. The latest transaction was disclosed on 4 March 2026 (Purchase). Regulator: DART (FSS). The full history is accessible without signup.
Kim Nam-joo is a director at Kanaf Therapeutics, a company specializing in innovative therapies. He is responsible for managing operations and developing new treatments. His expertise is essential for the company's success in the market.